The BioCanRx network is changing the face of cancer treatment

 

BioCanRx’s vision is to cure patients and enhance the quality of life of those living with cancer. We will do this by supporting world-class research in the area of immune oncology, and by accelerating to the clinic the most promising cancer immunotherapies designed to save lives and enable a better quality of life. Through an innovative, collaborative funding process BioCanRx is becoming a world-leader in the translation, manufacture and adoption of leading edge cancer immunotherapy treatments for the benefit of cancer patients.

 

 

for-resesarchers-1
for-resesarchers-1
for-resesarchers-1
for-resesarchers-1

 

 

 


Coming at cancer immunotherapy through macrophages

 

It started about five years ago, with a simple question: if T-cells can be activated to fight cancer, “why only do T-cells? What other ways are there of advancing immune responses in cancer?”

 

Learn more →


BioCanRx and Partners New Project Funding Announcement

 

BioCanRx and its partners today announce $1,917,833 in funding for two collaborative research projects and the second-stage funding of a current Catalyst project led by Dr. Simon Turcotte.

 

Learn more →


World Cancer Day 2018

 

Cancer is a disease that knows no boundaries. It is a leading cause of death worldwide, responsible for 8.8 million deaths per year. The disease is one of the biggest health challenges facing Canadians: 2 in every 5 of us will face a cancer diagnosis in our lifetime.

 

Learn more →

 

 

Summit for Cancer Immunotherapy

BANFF, ALBERTA
summitforcancer
Join the BioCanRx Network at the 3rd annual Summit for Cancer Immunotherapy (Summit4CI) taking place in Banff!

October 27-30, 2018

Fairmont Banff Springs

View Cancer Summit

Sponsorship Opportunities
Learning Institute Community Dissemination Report 2017

The participants of the 2017 BioCanRx-Cancer Stakeholder Alliance Learning Institute wish to share their Community Dissemination Report with the oncology patient and researcher community, BioCanRx, the Cancer Stakeholder Alliance, and the general public.

Click here for the full report
For the latest BioCanRx news and network activities:

Subscribe to our newsletter and email updates Subscribe
Follow us on Twitter
Like us on Facebook
Follow us on Instagram Follow
Subscribe to us on Youtube  Subscribe
Follow us on LinkedIn Follow